Acute lung rejection

An important factor for long term survival in lung transplantation

Zulkifli Amin, Ignatius Wuryantoro, Ceva Wijaksono, Elvina Johanna Yunasan

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Pulmonary transplantation has been used as treatment of choice in patients with advanced disease. Since the introduction of immunosuppressive and new advancement in postoperative management, the survival rate of lung transplantation has improved. However in the long run, survival rate decreases years after lung transplantation. According to ISHLTH 32 nd report, survival rate decreased to 54% after 5 years, and decreased to 31% after 10 years. Leading cause of mortality was found to be graft failure, which may be caused by acute rejection or chronic rejection. Based on the mechanism of action, acute rejection can be classified into acute cellular rejection (ACR), and antibody mediated rejection (AMR). Due to unspecific signs and symptoms in acute rejection, diagnostic procedures must be conducted to help diagnosis. Various modalities are available, but lung biopsy is still considered as the gold standard. Treatment for acute rejection varies in different centers. There are no published guidelines discussing treatment for lung rejection due to lack of published evidence. Further studies evaluating the pathogenesis, diagnosis modalities, and treatment of choice for acute rejection are needed to improve patients’ survival rate.

Original languageEnglish
Pages (from-to)617-621
Number of pages5
JournalIndian Journal of Public Health Research and Development
Volume10
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Lung Transplantation
Survival Rate
Lung
Survival
Therapeutics
Immunosuppressive Agents
Signs and Symptoms
Guidelines
Transplants
Biopsy
Mortality
Antibodies

Keywords

  • Acute cellular rejection (ACR)
  • Antibody mediated rejection (AMR)

Cite this

@article{0f88411c46314b1592c4cb06c69b9122,
title = "Acute lung rejection: An important factor for long term survival in lung transplantation",
abstract = "Pulmonary transplantation has been used as treatment of choice in patients with advanced disease. Since the introduction of immunosuppressive and new advancement in postoperative management, the survival rate of lung transplantation has improved. However in the long run, survival rate decreases years after lung transplantation. According to ISHLTH 32 nd report, survival rate decreased to 54{\%} after 5 years, and decreased to 31{\%} after 10 years. Leading cause of mortality was found to be graft failure, which may be caused by acute rejection or chronic rejection. Based on the mechanism of action, acute rejection can be classified into acute cellular rejection (ACR), and antibody mediated rejection (AMR). Due to unspecific signs and symptoms in acute rejection, diagnostic procedures must be conducted to help diagnosis. Various modalities are available, but lung biopsy is still considered as the gold standard. Treatment for acute rejection varies in different centers. There are no published guidelines discussing treatment for lung rejection due to lack of published evidence. Further studies evaluating the pathogenesis, diagnosis modalities, and treatment of choice for acute rejection are needed to improve patients’ survival rate.",
keywords = "Acute cellular rejection (ACR), Antibody mediated rejection (AMR)",
author = "Zulkifli Amin and Ignatius Wuryantoro and Ceva Wijaksono and Yunasan, {Elvina Johanna}",
year = "2019",
month = "1",
day = "1",
doi = "10.5958/0976-5506.2019.00121.9",
language = "English",
volume = "10",
pages = "617--621",
journal = "Indian Journal of Public Health Research and Development",
issn = "0976-0245",
publisher = "R.K. Sharma, Institute of Medico-Legal Publications",
number = "1",

}

Acute lung rejection : An important factor for long term survival in lung transplantation. / Amin, Zulkifli; Wuryantoro, Ignatius; Wijaksono, Ceva; Yunasan, Elvina Johanna.

In: Indian Journal of Public Health Research and Development, Vol. 10, No. 1, 01.01.2019, p. 617-621.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Acute lung rejection

T2 - An important factor for long term survival in lung transplantation

AU - Amin, Zulkifli

AU - Wuryantoro, Ignatius

AU - Wijaksono, Ceva

AU - Yunasan, Elvina Johanna

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Pulmonary transplantation has been used as treatment of choice in patients with advanced disease. Since the introduction of immunosuppressive and new advancement in postoperative management, the survival rate of lung transplantation has improved. However in the long run, survival rate decreases years after lung transplantation. According to ISHLTH 32 nd report, survival rate decreased to 54% after 5 years, and decreased to 31% after 10 years. Leading cause of mortality was found to be graft failure, which may be caused by acute rejection or chronic rejection. Based on the mechanism of action, acute rejection can be classified into acute cellular rejection (ACR), and antibody mediated rejection (AMR). Due to unspecific signs and symptoms in acute rejection, diagnostic procedures must be conducted to help diagnosis. Various modalities are available, but lung biopsy is still considered as the gold standard. Treatment for acute rejection varies in different centers. There are no published guidelines discussing treatment for lung rejection due to lack of published evidence. Further studies evaluating the pathogenesis, diagnosis modalities, and treatment of choice for acute rejection are needed to improve patients’ survival rate.

AB - Pulmonary transplantation has been used as treatment of choice in patients with advanced disease. Since the introduction of immunosuppressive and new advancement in postoperative management, the survival rate of lung transplantation has improved. However in the long run, survival rate decreases years after lung transplantation. According to ISHLTH 32 nd report, survival rate decreased to 54% after 5 years, and decreased to 31% after 10 years. Leading cause of mortality was found to be graft failure, which may be caused by acute rejection or chronic rejection. Based on the mechanism of action, acute rejection can be classified into acute cellular rejection (ACR), and antibody mediated rejection (AMR). Due to unspecific signs and symptoms in acute rejection, diagnostic procedures must be conducted to help diagnosis. Various modalities are available, but lung biopsy is still considered as the gold standard. Treatment for acute rejection varies in different centers. There are no published guidelines discussing treatment for lung rejection due to lack of published evidence. Further studies evaluating the pathogenesis, diagnosis modalities, and treatment of choice for acute rejection are needed to improve patients’ survival rate.

KW - Acute cellular rejection (ACR)

KW - Antibody mediated rejection (AMR)

UR - http://www.scopus.com/inward/record.url?scp=85062855335&partnerID=8YFLogxK

U2 - 10.5958/0976-5506.2019.00121.9

DO - 10.5958/0976-5506.2019.00121.9

M3 - Article

VL - 10

SP - 617

EP - 621

JO - Indian Journal of Public Health Research and Development

JF - Indian Journal of Public Health Research and Development

SN - 0976-0245

IS - 1

ER -